Successive Delivery Of Medicinal Products Containing Alirocumab, Rosuvastatin And Inclisiran For The Implementation Of The Picolo-Fh Research Project

  Address - Poland

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102547518

  Document Type - Tender Notices

Description - Description: The subject of the order of this procedure is: Successive delivery of medicinal products containing alirocumab, rosuvastatin and inclisiran as part of the implementation of the research project: "ComParison of InClisiran Or aLirOcumab to standard therapy in pediatric Familial Hypercholesterolemia - the head-to-head PICOLO-FH clinical trial", 2023/ABM/01/00032, financed by the Medical Research Agency. The detailed description of the subject of the order is as follows:Appendix No. 2.1 to the SWZ - Description of the subject of the order - Package IAppendix No. 2.2 to the SWZ - Description of the subject of the order - Package IIAppendix No. 2.3 to the SWZ - Description of the subj

Gt Ref Id - 102547518

Deadline - Feb 06, 2025